View in EDS PDF Full Text

First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer.

Saved in:
Bibliographic Details
Title: First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer.
Authors: Mørk SK; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Kongsted P; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Westergaard MCW; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Albieri B; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Granhøj JS; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Donia M; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Martinenaite E; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.; IO Biotech Aps, Copenhagen, Denmark., Holmström MO; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Madsen K; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Kverneland AH; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Kjeldsen JW; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Holmstroem RB; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Lorentzen CL; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Nørgaard N; Department of Urology, Copenhagen University Hospital, Herlev, Denmark., Andreasen LV; Statens Serum Institut, Center for Vaccine Research, Copenhagen, Denmark., Wood GK; Statens Serum Institut, Center for Vaccine Research, Copenhagen, Denmark., Christensen D; Statens Serum Institut, Center for Vaccine Research, Copenhagen, Denmark., Klausen MS; EVAXION BIOTECH A/S, Hørsholm, Denmark., Hadrup SR; Department of Health Technology, Technical University of Denmark (DTU), HEALTH TECH, Kongens Lyngby, Denmark., Thor Straten P; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Andersen MH; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Svane IM; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.
Source: Frontiers in immunology [Front Immunol] 2023 Mar 14; Vol. 14, pp. 1122977. Date of Electronic Publication: 2023 Mar 14 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36999039
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: First in man study: Bcl-Xl_42-CAF<superscript>®</superscript>09b vaccines in patients with locally advanced prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mørk+SK%22">Mørk SK</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Kongsted+P%22">Kongsted P</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Westergaard+MCW%22">Westergaard MCW</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Albieri+B%22">Albieri B</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Granhøj+JS%22">Granhøj JS</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Donia+M%22">Donia M</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Martinenaite+E%22">Martinenaite E</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.; IO Biotech Aps, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Holmström+MO%22">Holmström MO</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Madsen+K%22">Madsen K</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Kverneland+AH%22">Kverneland AH</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Kjeldsen+JW%22">Kjeldsen JW</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Holmstroem+RB%22">Holmstroem RB</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Lorentzen+CL%22">Lorentzen CL</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Nørgaard+N%22">Nørgaard N</searchLink>; Department of Urology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Andreasen+LV%22">Andreasen LV</searchLink>; Statens Serum Institut, Center for Vaccine Research, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Wood+GK%22">Wood GK</searchLink>; Statens Serum Institut, Center for Vaccine Research, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Christensen+D%22">Christensen D</searchLink>; Statens Serum Institut, Center for Vaccine Research, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Klausen+MS%22">Klausen MS</searchLink>; EVAXION BIOTECH A/S, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Hadrup+SR%22">Hadrup SR</searchLink>; Department of Health Technology, Technical University of Denmark (DTU), HEALTH TECH, Kongens Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Thor+Straten+P%22">Thor Straten P</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Andersen+MH%22">Andersen MH</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Svane+IM%22">Svane IM</searchLink>; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Mar 14; Vol. 14, pp. 1122977. <i>Date of Electronic Publication: </i>2023 Mar 14 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36999039
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2023.1122977
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1122977
    Titles:
      – TitleFull: First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mørk SK
      – PersonEntity:
          Name:
            NameFull: Kongsted P
      – PersonEntity:
          Name:
            NameFull: Westergaard MCW
      – PersonEntity:
          Name:
            NameFull: Albieri B
      – PersonEntity:
          Name:
            NameFull: Granhøj JS
      – PersonEntity:
          Name:
            NameFull: Donia M
      – PersonEntity:
          Name:
            NameFull: Martinenaite E
      – PersonEntity:
          Name:
            NameFull: Holmström MO
      – PersonEntity:
          Name:
            NameFull: Madsen K
      – PersonEntity:
          Name:
            NameFull: Kverneland AH
      – PersonEntity:
          Name:
            NameFull: Kjeldsen JW
      – PersonEntity:
          Name:
            NameFull: Holmstroem RB
      – PersonEntity:
          Name:
            NameFull: Lorentzen CL
      – PersonEntity:
          Name:
            NameFull: Nørgaard N
      – PersonEntity:
          Name:
            NameFull: Andreasen LV
      – PersonEntity:
          Name:
            NameFull: Wood GK
      – PersonEntity:
          Name:
            NameFull: Christensen D
      – PersonEntity:
          Name:
            NameFull: Klausen MS
      – PersonEntity:
          Name:
            NameFull: Hadrup SR
      – PersonEntity:
          Name:
            NameFull: Thor Straten P
      – PersonEntity:
          Name:
            NameFull: Andersen MH
      – PersonEntity:
          Name:
            NameFull: Svane IM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 03
              Text: 2023 Mar 14
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1